At Stratos Genomics We Don’t Believe in Impossible

 To make the next generation of DNA sequencing possible, we’ve combined cutting-edge biochemistry, chemistry, physics and engineering with grit, experience, tenacity and a never-ending curiosity.


Management Team


Mark Kokoris

President, CEO and Board Member

20+ years of experience working on the cutting edge of biotechnology. Mr. Kokoris’s passion is to conceive and develop innovative and transformative technologies. He co-founded Stratos Genomics in 2007 in order to pursue a vision of creating a next generation DNA sequencing technology that would enable broader use in healthcare. In pursuit of this goal, Mr. Kokoris co-invented the SBX™ technology that same year. In 2003, he founded the biotechnology consulting firm BioCaptus, LLC where his experience in the fields of high throughput genomics, molecular diagnostics, protein engineering and microfluidics was utilized by clients to develop a broad range of technologies and applications. Prior to forming BioCaptus, Mr. Kokoris was the Director of Services and Technology for QIAGEN Genomics, Inc. He was responsible for QGI’s entire genomic services offering as well as all aspects of technology and process development. As one of the founding members of Rapigene, he played a key role in the development of the Cleavable Mass Spec Tag (CMST) technology and in establishing the company’s high-throughput genotyping facility. Mr. Kokoris, who is an inventor or co-inventor on 10 issued US patents, holds a B.S. in Biochemistry from the University of California, Davis.


Bob McRuer, Ph.D.

CTO and Board Member

25+ years of instrumentation design, optics/electro optics and project management experience. Dr. McRuer’s product development experience includes detection and measurement systems for life science and medical products, fluorescence microscopy, SPR, image analysis, thermal control, microfluidics, electrowetting, laser scanning and liquid crystals. He has expertise in plastic optics manufacturing, optomechanical design, diffractive/micro optics, illumination, microdisplays, thin film development and metrology. Previous positions include Chief Technical Officer at Stratos Product Development, Senior Optical Engineer at Virtual IO, Senior Optical Engineer at iOptics and Researcher at Schlumberger Wireline. Dr. McRuer is an inventor on 14 issued US patents. He holds a Ph.D. in Electrical Engineering from Stanford.


John Tabone, Ph.D.

Vice President, Chemistry

25+ years in a startup environment developing innovative technologies in the areas of nucleoside chemistry, molecular diagnostics, genomic measurement, and high throughput automation of oligonucleotide and gene synthesis.  Dr. Tabone led design and implementation of a highly automated scalable gene manufacturing platform for a leading US gene synthesis company, Blue Heron Biotech. While at Microprobe, he managed the late stage development and manufacture of a 510k-approved DNA diagnostic. He was an inventor of the CMST SNP mass spectrometry-based measurement technology and led its development through to an early commercial stage.  Previous positions include Vice President of Technology Development at Blue Heron Biotech., Director of Technology Development at Rapigene, Inc., Senior Scientist at Darwin Molecular Corporation and Senior Scientist/Manager at Microprobe Corporation. Dr. Tabone is an inventor or co-inventor on 23 issued US patents. He received a B.S. in Chemistry from St. John’s University and a Ph.D. in Medicinal Chemistry from the University of Minnesota, Minneapolis.


Melud Nabavi

Vice President, Molecular Engineering

20+ years of experience in biotechnology developing innovative genomics technologies.   Mr. Nabavi joined Stratos Genomics in 2010 leading the Molecular Engineering effort.  In 2003, he was a founding member of BioCaptus developing technologies and applications for clients in high throughput genomics, microfluidics and molecular diagnostics.  Melud transitioned in 2007 to consult for Merck/Rosetta Inpharmatics evaluating and implementing molecular profiling technologies.  Before BioCaptus, Melud held several positions in high-throughput genomics technologies as a Manager and R&D Associate at QIAGEN Genomics, Inc., Cereon Genomics (Monsanto), Eli Lilly and received his initial research training at Oregon Health & Science University.  Melud is an inventor on two issued US patents and holds a B.S. degree from Portland State University. 


Danielle Jones


15+ years of experience in accounting and finance. Ms. Jones joined Stratos Genomics as Chief Financial Officer in June 2017 and is responsible for managing the company’s finances, as well as human resources.  Previous positions include Controller at Stratos Product Development and Assistant Controller at Mutual of Enumclaw Insurance Company.  She began her career in the audit practice at KPMG.  She holds a B.B.A. in Accounting from Southern Methodist University, Master in Professional Accounting from the University of Texas at Austin and is a CPA.



Additional Board Members


Lee Huntsman

Stratos Genomics

President Emeritus,
University of Washington

Harold Kawaguchi

Stratos Group, LLC

Stephen L. Rose

Managing Director,
Fisk Ventures, LLC

Heiner Dreismann

Retired CEO,
Roche Molecular Systems



Scientific Advisory Board


Andre Marziali

Founder, President and Chief Science Officer,
Boreal Genomics

Professor of Physics and Astronomy,
University of British Columbia


Patrick Stayton

Professor of Bioengineering,
University of Washington


Jay Shendure
MD, Ph.D.

Professor of Genome Sciences,
University of Washington


Lawrence A. Loeb
MD, Ph.D.

Professor of Pathology and Biochemistry,
University of Washington


Bob Franza

Affiliate Professor of Bioengineering,
University of Washington


Eugene Kolker

Chief Data Officer,
IBM Services


Buddy D. Ratner

Professor of Bioengineering,
University of Washington


Todd M. Smith

Biotechnology Innovator and Entrepreneur